1. LongstrethGF, ThompsonWG, CheyWD, et al.Functional bowel disorders. Gastroenterology2006;130:1480. CrossRef

2. StrocchiA, LevittMD. Intestinal gas. In: SleisengerF, ScharschmidtF(eds). Gastrointestinal Disease: Pathophysiology Diagnosis Management, Vol. 1, 5th edn. 1993: 1035.

3. SuarezF, FurneJ, SpringfieldJ, et al.Insights into human colonic physiology obtained from the study of flatus composition. Am J Physiol1997;272:G1028.

4. KantorJL. A study of atmospheric air in the upper digestive tract. Am J Med Sci1998;155:829. CrossRef

5. LevittMD, BondJH. Volume, composition and source of intestinal gas. Gastroenterology1970;59:921.

6. LevittMD, FrenchP, DonaldsonRM. Use of hydrogen and methane excretion in the study of the intestinal flora. J Lab Clin Med1968;72:988.

7. TomlinJ, LowisC, ReadNW. Investigation of normal flatus production in healthy volunteers. Gut1991;32:665. CrossRef

8. KirkE. The quantity and composition of human colonic flatus. Gastroenterology1949;12:782.

9. BedellGN, MarshallR, DuboisAB, et al.Measurement of the volume of gas in the gastrointestinal tract. J Clin Invest1956;35:336. CrossRef

10. RothJLA. Gaseousness. In: BerkJE(ed). Bockus Gastroenterology. Philadelphia: W B Saunders; 1985: 142.

11. KahrilasPJ, LogemannJA, ShohV, et al.Upper esophageal sphincter opening and modulation during swallowing. Gastroenterology1998;97:1467.

12. EngelRR, LevittMD. Intestinal tract gas formation in newborns (abstract). In: Program for meeting of American Pediatric Society and Society for Pediatric Research1970: 266.

13. CummingsJH. Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol1984;19:89.

14. PermanJA, ModlerS. Glycoproteins as substrates for production of hydrogen and methane by colonic bacterial flora. Gastroenterology1982;82:911.

15. StrocchiA, LevittMD. Factors affecting hydrogen production and consumption by human fecal flora: the critical roles of hydrogen tension and methanogenesis. J Clin Invest1992;89:1304. CrossRef

16. LevittMD. Production and excretion of hydrogen gas in man. N Engl J Med1969;281:122. CrossRef

17. SahakianAB, JeeSR, PimentelM. Methane and the gastrointestinal tract. Dig Dis Sci2010;55:2135. CrossRef

18. GibsonGR. Physiology and ecology of sulfate‐reducing bacteria. J Appl Bacteriol1990;69:769. CrossRef

19. PimentelM, MathurR, ChangC. Gas and the microbiome. Curr Gastroenterol Rep2013;15:356. CrossRef

20. MillerTL, WolinMJ. Enumeration of Methanobrevibacter smithii in human species. Arch Microbiol1982;131:14. CrossRef

21. PatelVP, JainNK, PitchumoniCS. Factors affecting fasting breath hydrogen levels in healthy adults. A study in two continents. Am J Gastroenterol1986;81:771.

22. PeledY, GilantT, LibermanE, et al.The development of methane production in childhood and adolescence. J Pediatr Gastroenterol Nutr1985;4:575. CrossRef

23. LevittMD, DuaneWC. Floating stools – flatus versus fat. N Engl J Med1972;286:973. CrossRef

24. LevittMD. Intestinal gas production. J Am Diet Assoc1972;60:487.

25. PermanJA, SaltzburgDM. Approach to the patient with gas and bloating. In: YamadaT, AlpersDH, OwyangC, et al. (ed.). Yamada Textbook of Gastroenterology. Philadelphia: J B Lippincott; 1992: 681.

26. MedaniM, CollinsD, DochertyNG, et al.Emerging role of hydrogen sulphide in colonic physiology and pathophysiology. Inflam Bowel Dis2011;17:1620. CrossRef

27. SchemannM, GrundyD. Role of hydrogen sulphide in visceral nociception. Gut2009;58:744. CrossRef

28. WangR. Physiological implications of hydrogen sulphide: a whiff exploration that blossomed. Physiol Rev2012;92:791. CrossRef

29. SchichoR, KruegerD, ZellerF, et al.Hydrogen sulphide is a novel pro‐secretory neuromodulator in the Guinea‐pig and human colon. Gastroenterology2006;131:1542. CrossRef

30. CannPA, ReadNW, BrownC, et al.The irritable bowel syndrome (IBS). Relationship of disorders in the transit of a single solid meal to symptom patterns. Gut1983;24:405. CrossRef

31. MaxtonDG, MartinDF, WhorwellPJ, et al.Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms. Gut1991;32:662. CrossRef

32. HaslerWL. Approach to the patient with gas and bloating. In: Yamada, T, AlpersDH, KallooAN, et al. (ed). Principles of Clinical Gastroenterology. Oxford: Blackwell Publishing; 2008: 255. CrossRef

33. LasserRB, BondJH, LevittMD. The role of intestinal gas in functional abdominal pain. N Engl J Med1975;293:524. CrossRef

34. HaslerWL. Irritable bowel syndrome and bloating. Best Pract Res Clin Gastroenterol2007;21:689. CrossRef

35. AzpirozF, MalageladaJR. Abdominal bloating. Gastroenterology2005;129:1060. CrossRef

36. ReadNW. Irritable bowel syndrome (IBS) Definition and pathophysiology. Scand J Gastroenterol1987;22:7. CrossRef

37. LevittMD. Volume and composition of human intestinal gas. N Engl J Med1971;284:1394. CrossRef

38. HockingMP, MaherJW, WoodwardER. Definitive surgical therapy for incapacitating “gas‐bloat” syndrome. Am Surg1982;48:131.

39. WallsADF, GonzalesJG. The incidence of gas‐bloat syndrome and dysphagia following fundoplication for hiatus hernia. J R Coll Surg Edinb1977;22:391.

40. PessauxP, ArnaudJP, DelattreJF, et al.Laparoscopic antireflux surgery: five‐year results and beyond in 1340 patients. Arch Surg2005;140:946. CrossRef

41. RossettiM, HellK. Fundoplication for the treatment of gastroesophageal reflux in hiatal hernia. World J Surg1977;1:439. CrossRef

42. CallowayDH, MurphyEL. The use of expired air to measure intestinal gas formation. Ann N Y Acad Sci1968;150:82. CrossRef

43. BeazellJM, IvyAC. The quantity of colonic flatus excreted by the normal individual. Am J Dig Dis1941;8:128. CrossRef

44. MooreJG, JessopLD, OsborneDN. A gas chromatographic and mass spectrometric analysis of the odor of human feces. Gastroenterology1987;93:1321.

45. KambojSK, LanghoffC, PajakR, et al.Bowel and bladder‐control anxiety: a preliminary description of a viscerally‐centered phobic syndrome. Behav Cogn Psychother2013;19:1.

46. RaoSS, TutejaAK, VellemaT, et al.Dyssynergic defecation: demographics, symptoms, stool patterns, and quality of life. J Clin Gastroenterol2004;38:680. CrossRef

47. SerraJ, AzpirozF, MalageladaJR. Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol2001;281:G138.

48. VonderOHE, CamilleriM. Measurement of small bowel and colonic transit. Indications and methods. Mayo Clin Proc1992;67:1167.

49. RaoSS, CamilleriM, HaslerWL, et al.Evaluation of gastrointestinal transit in clinical practice: position paper of the American And European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil2011;23;8. CrossRef

50. SolomonsNW. Evaluation of carbohydrate absorption: the hydrogen breath test in clinical practice. Clin Nutr1984;3:71.

51. KingCE, ToskesPP. The uses of breath tests in the study of malabsorption. Clin Gastroenterol1983;12:591.

52. ReadNW, MilesCA, FisherD, et al.Transit of a meal through the stomach, small intestine and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology1980;79:1276.

53. SimrenM, StotzerPO. Use and abuse of hydrogen breath tests. Gut2006;55:297. CrossRef

54. SaadRJ, CheyWD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol2013. doi/10.1016/j.cgh.2013.09.055.

55. RuppinH, Bar‐MeirS, SoergelKH, et al.Absorption of short chain fatty acids by the colon. Gastroenterology1983;78:1500.

56. SilkDB, DawsonAM. Intestinal absorption of carbohydrate and protein in man. Int Rev Physiol1979;19:151.

57. CorazzaGR, StrocchiA, SorgeM, et al.The measurement of breath methane (CH4) must be combined with hydrogen (H2) measurement in the diagnosis of carbohydrate malabsorption (abstract). Italian J Gastroenterol1991;23:A516.

58. DiPalmaJA, MarvaezRM. Prediction of lactose malabsorption in referral patients. Dig Dis Sci1988;33:303. CrossRef

59. NarvaezRM, DipalinaJA, PiersonWP. Patient awareness of lactose associated symptoms. Gastroenterology1986;90:A1562.

60. RaoSS. Belching, bloating and flatulence. How to help patients with troublesome abdominal gas. Postgrad Med1997;101:263, 275–8.

61. CallowayDH, MurphyEL, BauerD. Determination of lactose intolerance by breath analysis. Am J Dig Dis1969;14:811. CrossRef

62. MetzG, GassullMA, LeedsAR, et al.A simple method of measuring breath hydrogen in carbohydrate malabsorption by end‐expiratory sampling. Clin Sci Mol Med1976;50:237.

63. ReadNW, Al‐JanabiNM, BatesTE. Interpretation of the breath hydrogen profile obtained after ingesting a solid meal containing unabsorbable carbohydrate. Gut1985;26:834. CrossRef

64. RaoSS, AttaluriA, AndersonL, et al.The ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol2007;5:959. CrossRef

65. ChoiYK, JohlinFCJr, SummersRW, et al.Fructose intolerance: an under‐recognized problem. Am J Gastroenterol2003;98:1348. CrossRef

66. BateJP, IrvingPM, BarrettJS, et al.Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol2010;22:318. CrossRef

67. JacobsC, Coss AdameE, AttaluriA, et al.Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth. Aliment Pharmacol Ther2013;37:1103. CrossRef

68. ChoungRS, RuffKC, MalhotraA, et al.Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther2011;33:1059. CrossRef

69. RatuapliSK, EllingtonTG, O'NeillMT, et al.Proton pump inhibitor therapy does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol2012;107:730. CrossRef

70. QuigleyEM, QueraR. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology2006;130:S78. CrossRef

71. ErdoganA, GulleyD, JacobsC, et al.Small intestinal bacterial overgrowth (SIBO): duodenal aspirate vs glucose breath test (GBT). Neurogastroenterol Motil2013;25(Suppl 1):7.

72. KhoshiniR, DaiSC, LezcanoS, et al.A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci2008;53:1443. CrossRef

73. ShahED, BasseriRJ, ChongK, et al.Abnormal breath testing in IBS: a meta‐analysis. Dig Dis Sci2010;55:2441. CrossRef

74. RiordanSM, McIverCJ, WalkerBM, et al.The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol1996;91:1795.

75. LevittMD, LasserRB, SchwartzJS, et al.Studies of a flatulent patient. N Engl J Med1976;295:260. CrossRef

76. VesaTH, MarteauP, KorpelaR. Lactose intolerance. J Am Coll Nutr2000;19:165S. CrossRef

77. IngramCJ, MulcareCA, ItanY, et al.Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet2009;12:579. CrossRef

78. NewcomerAD, McGillDB, ThomasPJ, et al.Prospective comparison of indirect methods for detecting lactose deficiency. N Engl J Med1975;293:1232. CrossRef

79. LerchM, RiebrandHC. Concordance of indirect methods for the detection of lactose malabsorption in diabetic and nondiabetic subjects. Digestion1991;48:81. CrossRef

80. HieleM, GhoosY, RutgeertsP, et al.13CO2 breath test using naturally 13C‐enriched lactose for detection of lactose deficiency in patients with gastrointestinal symptoms. J Lab Clin Med1988;112:193.

81. RumessenJJ. Fructose and related food carbohydrates. Sources, intake, absorption, and clinical implications. Scand J Gastroenterol1992;27:819. CrossRef

82. Wilder‐SmithCH, LiX, HoSSY, et al.Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance. United Eur Gastroenterol J2014;2:14. CrossRef

83. RibyJE, FujisawaT, KretchmerN. Fructose absorption. Am J Clin Nutr1993;58:748S.

84. ShepherdSJ, GibsonPR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc2006;106:1631. CrossRef

85. JohlinFCJr, PantherM, KraftN. Dietary fructose intolerance: diet modification can impact self‐rated health and symptom control. Nutr Clin Care2004;7:92.

86. KomerickiP, Akkilic‐MaternaM, StrimitzerT, et al.Oral xylose isomerase decreases breath hydrogen excretion and improves gastrointestinal symptoms in fructose malabsorption – a double‐blind placebo‐controlled study. Aliment Pharmacol Ther2012;36:980. CrossRef

87. GibsonPR, ShepherdSJ. Evidence‐based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol2010;25:252. CrossRef

88. ShepherdSJ, LomerMC, GibsonPR. Short‐chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol2013;108:707. CrossRef

89. HalmosEP, PowerVA, ShepherdSJ, et al.A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology2014;146:67. CrossRef

90. RoberfroidMB. Introducing inulin‐type fructans. Br J Nutr2005;93(Suppl 1):S13. CrossRef

91. DonahoeR, AttaluriA, SchneiderM, et al.Absorptive capacity of fructans in healthy humans: a dose response study. Gastroenterology2010;138(Suppl 1):S709. CrossRef

92. MuirJG, ShepherdSJ, RosellaO, et al.Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem2007;55:6619. CrossRef

93. Fernandez‐BanaresF, EsteveM, ViverJM. Fructose‐sorbitol malabsorption. Curr Gastroenterol Rep2009;11:368. CrossRef

94. StaudacherHM, WhelanK, IrvingPM, et al.Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet2011;24:487. CrossRef

95. StaudacherHM, LomerMC, AndersonJL, et al.Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr2012;142:1510. CrossRef

96. JainNK, RosenbergDB, UlahannanMJ, et al.Sorbitol intolerance in adults. Am J Gastroenterol1985;80:678.

97. HymansJS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology1983;84:30.

98. HyamsJS. Chronic abdominal pain caused by sorbitol malabsorption. J Pediatr1982;100:772. CrossRef

99. SanderP, AlfalahM, KeiserM, et al.Novel mutations in the human sucrase‐isomaltase gene (SI) that cause congenital carbohydrate malabsorption. Hum Mutat2006;27:119. CrossRef

100. AlfalahM, KeiserM, LeebT, et al.Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase‐isomaltase deficiency. Gastroenterology2009;136:883. CrossRef

101. Robayo‐TorresCC, OpekunAR, Quezada‐CalvilloR, et al.13C‐breath tests for sucrose digestion in congenital sucrase isomaltase‐deficient and sacrosidase‐supplemented patients. J Pediatr Gastroenterol Nutr2009;48:412. CrossRef

102. OuwendijkJ, MoolenaarCE, PetersWJ, et al.Congenital sucrase‐isomaltase deficiency. Identification of a glutamine to proline substitution that leads to a transport block of sucrase‐isomaltase in a pre‐Golgi compartment. J Clin Invest1996;97:633. CrossRef

103. LedochowskiM, WidnerB, BairH, et al.Fructose‐ and sorbitol‐reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol2000;35:1048. CrossRef

104. TreemWR. Clinical aspects and treatment of congenital sucrase‐isomaltase deficiency. J Pediatr Gastroenterol Nutr2012;55(Suppl 2):S7. CrossRef

105. GorbachSL, TabaqchaliS. Bacteria, bile and the small bowel. Gut1969;10:963. CrossRef

106. TabaqchaliS, BoothCC. Jejunal bacteriology and bile‐salt metabolism in patients with intestinal malabsorption. Lancet1966;2:12. CrossRef

107. SimrenM, BarbaraG, FlintHJ, et al.Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut2013;62:159. CrossRef

108. O'HaraAM, ShanahanF. The gut flora as a forgotten organ. EMBO Rep2006;7:688. CrossRef

109. ElphickDA, ChewTS, HighamSE, et al.Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier?Gerontology2005;51:396. CrossRef

110. KayeSA, LimSG, TaylorM, et al.Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol1995;34:265. CrossRef

111. AttarA, FlourieB, RambaudJC, et al.Antibiotic efficacy in small intestinal bacterial overgrowth‐related chronic diarrhea: a crossover, randomized trial. Gastroenterology1999;117:794. CrossRef

112. BouhnikY, AlainS, AttarA, et al.Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol1999;94:1327. CrossRef

113. ShahSC, DayLW, SomsoukM, et al.Meta‐analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther2013;38:925. CrossRef

114. PimentelM, ChangC, Shari ChuaK, et al.Rifaximin and neomycin in the treatment of constipation IBS with methane as a biomarker on breath testing. Am J Gastroenterol2013;108(Suppl 1):S563.

115. GaonD, GarmendiaC, MurrieloNO, et al.Effect of Lactobacillus strains (L. casei and L. acidophilus strains cerela) on bacterial overgrowth‐related chronic diarrhea. Medicina (B Aires)2002;62:159.

116. UchidaH, YamamotoH, KisadiY, et al.D‐lactic acidosis in short bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg2004;39:634. CrossRef

117. StotzerPO, BlombergL, ConwayPL, et al.Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis1996;28:615. CrossRef

118. CamilleriM. Probiotics in irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol2008;42(Suppl 3):S123. CrossRef

119. KimHJ, CamilleriM, McKinzieS, et al.A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome. Aliment Pharmacol Ther2003;17:895. CrossRef

120. O'MahonyL, McCarthyJ, KellyP, et al.Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology2005;128:541. CrossRef

121. WhorwellPJ, AltringerL, MorelJ, et al.Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol2006;101:1581. CrossRef

122. BrennerDM, MoellerMJ, CheyWD, et al.The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol2009;104:1033. CrossRef

123. BittnerAC, CroffutRM, StranahanMC. Prescript‐Assist probiotic‐prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2‐week, randomized, placebo‐controlled, double‐blind clinical study. Clin Ther2005;27:755. CrossRef

124. JohnsonAG. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. BMJ1971;2:25. CrossRef

125. Van OutryveM, MiloR, ToussaintJ, et al.“Prokinetic” treatment of constipation‐predominant irritable bowel syndrome: a placebo controlled study of cisapride. J Clin Gastroenterol1991;13:49. CrossRef

126. RaoSS, SeatonK, MillerM, et al.Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol2007;5:331. CrossRef

127. WeberFH, McCallumRW. Clinical approaches to irritable bowel syndrome. Lancet1992;2:1447. CrossRef

128. WhorwellPJ, PriorA, ColganSM. Hypnotherapy in severe irritable bowel syndrome; further experience. Gut1987;28:423. CrossRef

129. WorkmanEM, Alun JonesV, WilsonAJ, et al.Diet in the management of Crohn's disease. Hum Nutr Appl Nutr1984;38:469.

130. SolomonsN, VasquezA, GraziosoC. Orally‐ingested, microbial alpha‐galactosidases produce effective in vivo, intraintestinal digestion of the bean oligosaccharide rattinose. Gastroenterology1991;100:A251.

131. GaniatsTG, NorcrossWA, HalversonAL, et al.Does Beano prevent gas? A double‐blind crossover study of oral alpha‐galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract1994;39:441.

132. HallRGJr, ThompsonH, StrotherA. Effects of orally administered activated charcoal on intestinal gas. Am J Gastroenterol1981;75:192.

133. JainNK, PatelVP, PitchumoniCS. Activated charcoal, l gas: a double‐blind study. Ann Intern Med1986;105:61. CrossRef

134. PotterT, EllisC, LevittMD. Activated charcoal: in vivo and in vitro studies of effect of gas formation. Gastroenterology1985;88:620.

135. WhiteJG, HightowerNC, RiggsM, et al.Does Activated charcoal relieve gas symptoms – a placebo controlled study. Gastroenterology1991;100:A261.

136. SuarezFL, FurneJK, SpringfieldJ, et al.Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology1998;114:923. CrossRef

137. SuarezFL, LevittMD. An understanding of excessive intestinal gas. Curr Gastroenterol Rep2000;2:413. CrossRef

138. BjorneklettA, JenssenE. Relationship between hydrogen (H2) and methane (CH4) production in man. Scand J Gastroenterol1982;17:985.

139. BernsteinJE, SchwartzSR. An evaluation of the effectiveness of simethicone in acute upper gastrointestinal distress. Curr Ther Res Clin Exp1974;16:617.

140. BernsteinJE, KasichAM. A double‐blind trial of simethicone in functional disease of the upper gastrointestinal tract. J Clin Pharmacol1974;14:617. CrossRef

141. YoungRW, BeregiJS. Use of chlorophyllin in the care of geriatric patients. J Am Geriatr Soc1980;28:46. CrossRef

142. RaoSS, EnckP, Loenin‐BauckeV. Biofeedback therapy for defecation disorders. Dig Dis1997;15(Suppl 1):78. CrossRef